| Dr Clayton Richard Perry Jr, MD | |
|
4100 Lake Dr Se Ste 300, Grand Rapids, MI 49546-8292 | |
| (616) 267-8860 | |
| Not Available |
| Full Name | Dr Clayton Richard Perry Jr |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 14 Years |
| Location | 4100 Lake Dr Se Ste 300, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083927396 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 4301096609 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Visiting Nurse Services Of Western Michigan | Grand rapids, MI | Home health agency |
| Spectrum Health | Grand rapids, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spectrum Health Primary Care Partners | 4587568647 | 1585 |
| Spectrum Health Hospitals | 8921904764 | 131 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced initiation of patient enrollment in the second part of the Company's randomized Phase 2 clinical program of ozarelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, in men with prostate cancer for whom hormonal treatment is indicated.
Complex new Medicare rules that seek to cut costs of home-oxygen therapy are confusing the more than one million people who rely on the federal insurer to pay for the coverage.
In a letter published in the August 21 issue of the journal The Lancet, Dr. Charles Baker, Vice President Scientific Affairs for the Sugar Association, outlined his rebuttal to a viewpoint published in The Lancet in March, 2004 that obesity is linked to increased sweetener consumption.
People from low socio-economic positions in Britain eat more salt than the well off, irrespective of where they live, states a paper led by Warwick Medical School published on Tuesday in the BMJ Open journal .
› Verified 8 days ago
| Entity Name | Mecosta County Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386693471 PECOS PAC ID: 1951215540 Enrollment ID: O20031118000335 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced initiation of patient enrollment in the second part of the Company's randomized Phase 2 clinical program of ozarelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, in men with prostate cancer for whom hormonal treatment is indicated.
Complex new Medicare rules that seek to cut costs of home-oxygen therapy are confusing the more than one million people who rely on the federal insurer to pay for the coverage.
In a letter published in the August 21 issue of the journal The Lancet, Dr. Charles Baker, Vice President Scientific Affairs for the Sugar Association, outlined his rebuttal to a viewpoint published in The Lancet in March, 2004 that obesity is linked to increased sweetener consumption.
People from low socio-economic positions in Britain eat more salt than the well off, irrespective of where they live, states a paper led by Warwick Medical School published on Tuesday in the BMJ Open journal .
› Verified 8 days ago
| Entity Name | Spectrum Health Primary Care Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235188673 PECOS PAC ID: 4587568647 Enrollment ID: O20031121000091 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced initiation of patient enrollment in the second part of the Company's randomized Phase 2 clinical program of ozarelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, in men with prostate cancer for whom hormonal treatment is indicated.
Complex new Medicare rules that seek to cut costs of home-oxygen therapy are confusing the more than one million people who rely on the federal insurer to pay for the coverage.
In a letter published in the August 21 issue of the journal The Lancet, Dr. Charles Baker, Vice President Scientific Affairs for the Sugar Association, outlined his rebuttal to a viewpoint published in The Lancet in March, 2004 that obesity is linked to increased sweetener consumption.
People from low socio-economic positions in Britain eat more salt than the well off, irrespective of where they live, states a paper led by Warwick Medical School published on Tuesday in the BMJ Open journal .
› Verified 8 days ago
| Entity Name | Spectrum Health Hospitals |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558407189 PECOS PAC ID: 8921904764 Enrollment ID: O20040120000997 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced initiation of patient enrollment in the second part of the Company's randomized Phase 2 clinical program of ozarelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, in men with prostate cancer for whom hormonal treatment is indicated.
Complex new Medicare rules that seek to cut costs of home-oxygen therapy are confusing the more than one million people who rely on the federal insurer to pay for the coverage.
In a letter published in the August 21 issue of the journal The Lancet, Dr. Charles Baker, Vice President Scientific Affairs for the Sugar Association, outlined his rebuttal to a viewpoint published in The Lancet in March, 2004 that obesity is linked to increased sweetener consumption.
People from low socio-economic positions in Britain eat more salt than the well off, irrespective of where they live, states a paper led by Warwick Medical School published on Tuesday in the BMJ Open journal .
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Clayton Richard Perry Jr, MD 100 Michigan St Ne # Mc845, Grand Rapids, MI 49503-2560 Ph: () - | Dr Clayton Richard Perry Jr, MD 4100 Lake Dr Se Ste 300, Grand Rapids, MI 49546-8292 Ph: (616) 267-8860 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced initiation of patient enrollment in the second part of the Company's randomized Phase 2 clinical program of ozarelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, in men with prostate cancer for whom hormonal treatment is indicated.
Complex new Medicare rules that seek to cut costs of home-oxygen therapy are confusing the more than one million people who rely on the federal insurer to pay for the coverage.
In a letter published in the August 21 issue of the journal The Lancet, Dr. Charles Baker, Vice President Scientific Affairs for the Sugar Association, outlined his rebuttal to a viewpoint published in The Lancet in March, 2004 that obesity is linked to increased sweetener consumption.
People from low socio-economic positions in Britain eat more salt than the well off, irrespective of where they live, states a paper led by Warwick Medical School published on Tuesday in the BMJ Open journal .
› Verified 8 days ago
Dr. Charles D Bukrey, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1111 Leffingwell Ave Ne, Suite 100, Grand Rapids, MI 49525 Phone: 616-459-7101 Fax: 616-464-6170 | |
John Mahajan, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4100 Lake Dr Se Ste 300, Grand Rapids, MI 49546 Phone: 616-267-8860 | |
Walter M Braunohler, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 4100 Lake Dr Se, Suite 300, Grand Rapids, MI 49546 Phone: 616-267-8860 Fax: 616-267-8442 | |
Scott David Burgess, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1111 Leffingwell Ave Ne, Suite 200, Grand Rapids, MI 49525 Phone: 616-459-7101 Fax: 616-464-6170 | |
Viet Huu Do, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1111 Leffingwell Ne, Suite 200, Grand Rapids, MI 49525 Phone: 616-459-7101 | |
Daniel Edward Hess, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4100 Lake Dr Se Ste 300, Grand Rapids, MI 49546 Phone: 616-267-8860 | |
Jacob Allen Lytle, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4100 Lake Dr Se Ste 300, Grand Rapids, MI 49546 Phone: 616-267-8860 |